Low-Tension Glaucoma, Unspecified Eye: Clinical Trials

1 trial for Low-Tension Glaucoma, Unspecified Eye, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Low-Tension Glaucoma, Unspecified Eye: new trials by email Literature Review of Low-Tension Glaucoma, Unspecified Eye trials Research Report on Low-Tension Glaucoma, Unspecified Eye

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)
QLS-111 ophthalmic solution (0.015%), Timolol Maleate PF 0.5% Ophthalmic Solution (Timolol) - Normal Tension Glaucoma (NTG), Low-Tension Glaucoma, Bilateral
Phase 2CompletedQlaris Bio, Inc.372025-08-132026-04-03

Narrower conditions

Glaucoma (1)  ·  Low Tension Glaucoma (1)

Broader conditions

Eye Diseases (1)  ·  Ocular Hypertension (1)  ·  Optic Nerve Diseases (1)

Interventions

Ophthalmic Solutions (1)  ·  Timolol (1)

Sponsors

Qlaris Bio, Inc. (1)

Countries

South Korea (1)

Top investigators

Lisa Brandano (1)